[Drug-induced and toxic myopathies]

M Coquet1, B Bannwarth, D Henin

  • 1Service d'anatomie pathologique et de neuropathologie, groupe hospitalier Pellegrin 33076 Bordeaux. michelle.coquet@chu.bordeaux.fr

La Revue Du Praticien
|March 27, 2001
PubMed

Insights

Toxic myopathies, induced by various drugs and toxins, are common and present diverse pathological mechanisms. Early diagnosis and agent discontinuation are crucial for reversibility and preventing severe outcomes.

Area of Science:

  • Neurology
  • Toxicology
  • Pathology

Context:

  • Drugs and toxins are frequently implicated in causing myopathic changes.
  • The prevalence of toxic myopathies may be underestimated in clinical practice.

Purpose:

  • To categorize the main types of toxic myopathies based on their pathological mechanisms.
  • To highlight the importance of recognizing and diagnosing drug-induced myopathies.

Summary:

  • Six main categories of toxic myopathies are identified: necrotizing, vacuolar, inflammatory, mitochondrial, steroid, and hypokalemic.
  • Clinical and pathological features vary depending on the causative agent and individual susceptibility.
  • Muscle biopsy is a valuable diagnostic tool for toxic myopathies.

Impact:

  • Prompt identification and cessation of the offending agent can lead to reversible myopathic changes.
  • Timely diagnosis can mitigate damaging effects and prevent potentially fatal outcomes associated with toxic myopathies.

Related Concept Videos

Drug Toxicity: Dose-Dependent Reactions01:24

Drug Toxicity: Dose-Dependent Reactions

Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Drug Toxicity: Overview01:00

Drug Toxicity: Overview

Drug toxicity quantifies the harm a compound causes to an organism, varying by dose and potentially impacting whole systems or specific organs like the liver. Toxic reactions may arise from venomous insect or spider bites, with effects ranging from mild symptoms to severe outcomes such as brain damage or death. Common forms of acute poisoning include ethanol intoxication and overdose of pain or fever medications, with substances like GHB and heroin being particularly lethal at doses close to...
Drug toxicity: Idiosyncratic Reactions01:16

Drug toxicity: Idiosyncratic Reactions

Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...
Drug Toxicity: Allergic Reactions01:30

Drug Toxicity: Allergic Reactions

Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial exposure to a...